Search results for: cancer
Symptoms and Screenings for Cancers of the Stomach, Esophagus and Liver
Arthur Winer, MD, is a specialty care physician at Inova Schar Cancer Institute. Dr. Winer is board-certified in internal medicine, hematology and medical oncology. He is a practicing gastrointestinal medical oncologist and has clinical interests in colorectal, esophageal, gastrointestinal, liver and pancreatic cancers. When it comes to symptoms and screenings, the most common forms of cancer…
Read MoreUnderstanding Risk: The First Step in Breast Cancer Prevention
Rebecca Kaltman, MD is a board-certified hematologist oncologist. She serves as the Medical Director of the Inova Saville Cancer Screening and Prevention Center. If there was just one thing I could say to a woman who asked me what she should do to prevent breast cancer, it would be simple: Know your risk. Knowing your…
Read MoreCancer Prevention Through Nutrition
Marion Irvin, RD, LD, CNSC, is a registered dietitian at the Inova Schar Cancer Institute and Life With Cancer. She is board-certified in nutrition support. Approximately 40 percent of all cancer cases can be attributed to modifiable risk factors. These are risk factors based on habits that are within our control. One large decision we…
Read MoreEndurance Sports and Colorectal Cancer: Is There a Connection?
Timothy L. Cannon, MD, is board certified in medical oncology, hematology and internal medicine. He serves as the Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program. After treating three ultramarathoners who had developed colorectal cancer in recent years, I had a suspicion: This could be more than a coincidence. I found…
Read MoreInova Saville Cancer Screening and Prevention Center Joins an International Effort to Fight Pancreatic Cancer
Raymond Wadlow, MD, is an oncologist at Inova Schar Cancer Institute. He is board-certified in Medical Oncology and Internal Medicine and has a special interest in gastrointestinal oncology. We know the realities of pancreatic cancer. It is a disease that caused 48,220 deaths in the United States in 2021, and 466,003 worldwide in 2020. It…
Read MoreNot A FLASH in the Pan: New Treatment Effective for Rare Skin Cancer
Jennifer DeSimone, MD, is board-certified in dermatology practicing at Inova Melanoma and Skin Cancer Center. Dr. DeSimone specializes in skin lymphomas and high-risk skin cancers. Her goal is to help educate her patients about skin cancer etiology, management and importantly, prevention. A new treatment for mycosis fungoides combines an extract from a common weed with…
Read MoreBy Fighting Skin Cancer Misconceptions, We Can Screen More Patients and Save More Lives
Patricia Lucey, MD, is a board-certified dermatologist at the Inova Melanoma and Skin Cancer Center. She has a special interest in the diagnosis and management of melanoma and other skin cancers. Skin cancer is the most prevalent form of cancer in the United States — a fact that can sound discouraging. But another fact we know…
Read MoreFighting a Cancer Epidemic With a Vaccine
John Deeken, MD, is president of the Inova Schar Cancer Institute. He is board-certified in medical oncology and specializes in head and neck cancers. Quitting smoking. Eating better. Wearing sunscreen. These are all well-known behaviors that can lower cancer risk. But there’s another, less-heralded way to reduce cancer odds: get vaccinated. Specifically, vaccination against the…
Read MoreIs Prostate Cancer Slow Growing? Often, Yes — But That’s Not the Whole Story
Prostate cancer, unlike other forms of cancer, often grows slowly. That fact can make screening, treatment and potential outcomes seem a little less intimidating. However, prostate cancer’s slow-growing tendency can obscure other, more complicated aspects of detection and treatment. First, decisions on when to get screened and how to respond to the results are complex,…
Read MoreStudy Finds New Therapy Effective for Common, Advanced Bladder Cancer
Following standard chemotherapy, Avelumab was found to increase the overall survival of patients with advanced urothelial bladder cancer. According to the North American Association of Central Cancer Registries, more than 80,000 Americans will be diagnosed with bladder cancer in 2022 with an anticipated loss of 17,000 patients to the disease. Most of these cases are…
Read More